This systematic review and meta-analysis demonstrates that elevated high-sensitivity cardiac troponin T (hs-cTnT) levels are strongly associated with adverse clinical outcomes in patients with heart failure (HF), including increased all-cause mortality, cardiovascular mortality, and cardiovascular hospitalizations. Here, TNNT2 is linked to heart failure.